APTEVO RESEARCH AND DEVELOPMENT
Live / Applied — Statement of use — registration review complete (as of 29 Sept 2025)
What this means for you
Not registered yet, but its 08 Sept 2020 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90165938
- Mark type
- Stylized text
- Filed
- 08 Sept 2020
- Published for opposition
- 12 Jul 2022
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prophylaxis of infectious diseases, immune system diseases and disorders, auto immune system diseases, and blood disorders, none of the foregoing related to oncology
Owner
- APTEVO RESEARCH AND DEVELOPMENT LLC, Seattle, WA, US
- APTEVO RESEARCH AND DEVELOPMENT LLC, Seattle, WA, US
Prosecution history
- 29 Sept 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Sept 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Sept 2025 — USE AMENDMENT FILED
- 08 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 04 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jul 2025 — SOU EXTENSION 5 GRANTED
- 04 Mar 2025 — SOU EXTENSION 5 FILED
- 01 Jul 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Aug 2024 — SOU EXTENSION 4 GRANTED
- 30 Aug 2024 — SOU EXTENSION 4 FILED
- 30 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 07 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED